首页> 外国专利> Wortmannin phosphoinositide 3-kinase interaction site

Wortmannin phosphoinositide 3-kinase interaction site

机译:Wortmannin磷酸肌醇3激酶相互作用位点

摘要

The site of interaction of wortmannin on the catalytic subunit of PI3-kinase, p110 alpha is identified. At physiological pH (6.5-8) wortmannin reacted specifically with p110 alpha . PtdIns (4.5)P2, ATP and ATP-analogs (adenine and 5'(4-fluorosulfonylbenzoyl)-adenine, FSBA) completed effectively with wortmannin, while substances containing nucleophilic amino acid side chain functions had no effect at the same concentrations. Proteolytic fragments of wortmannin-treated, recombinant p110 alpha are mapped using anti-wortmannin and anti-p110 alpha peptide antibodies, thus limiting the target site within a 10 kD fragment, co-localizing with the ATP binding site. Site-directed mutagenesis of all candidate residues within this region shows that only the conservative Lys802 to Arg mutation abolished wortmannin binding. Inhibition of PI3-kinase occurs therefore by the formation of an enamine following the attack of Lys802 on the furan ring (at C20) of wortmannin. The Lys802Arg mutant was also unable to bind FSBA, and was catalytically inactive in lipid and protein kinase assays, indicating a crucial role for Lys802 in the phosphotransfer reaction. In contrast, an Arg916Pro mutation abolished the catalytic activity, while covalent wortmannin binding remained intact.
机译:鉴定了渥曼青霉素在PI3-激酶的催化亚基p110α上的相互作用的位点。在生理pH(6.5-8)下,渥曼青霉素与p110α特异性反应。 PtdIns(4.5)P2,ATP和ATP类似物(腺嘌呤和5'(4-氟磺酰基苯甲酰基)-腺嘌呤,FSBA)用渥曼青霉素有效完成,而含有亲核氨基酸侧链功能的物质在相同浓度下没有作用。使用抗渥曼青霉素和抗p110α肽抗体对渥曼青霉素处理过的重组p110 alpha的蛋白水解片段进行定位,从而将目标位点限制在10 kD片段内,与ATP结合位点共定位。该区域内所有候选残基的定点诱变表明,只有保守的Lys802到Arg突变消除了渥曼青霉素的结合。因此,在赖氨酸802攻击渥曼青霉素的呋喃环上(在C20处)后形成烯胺,从而抑制了PI3-激酶。 Lys802Arg突变体也无法结合FSBA,并且在脂质和蛋白激酶测定中无催化活性,表明Lys802在磷酸转移反应中起关键作用。相反,Arg916Pro突变取消了催化活性,而共价渥曼青霉素的结合保持完整。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号